Search research articles
Contact Us
Filters
Showing results (71-80 of 246) with videos related to
Page
of 25
Sort By:
Clinical and Experimental Pharmacology & Physiology
|
March 1, 2008
Angiotensin converting enzyme 2 in the kidney
A Koitka, M E Cooper, M C Thomas, et al.
The Medical Journal of Australia
|
November 10, 2001
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes
G Jerums, M E Cooper, R E Gilbert, et al.
Diabetes
|
April 1, 1993
The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy
R C O'Brien, M E Cooper, G Jerums, et al.
Kidney International
|
August 1, 1996
Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment
T Soulis, M E Cooper, D Vranes, et al.
Diabetologia
|
April 6, 2006
Anaemia in diabetes: Is there a rationale to TREAT?
M C Thomas, M E Cooper, K Rossing, et al.
Clinical and Experimental Pharmacology & Physiology
|
August 1, 1989
Ramipril reduces albuminuria in diabetic rats fed a high protein diet
R C O'Brien, M E Cooper, T J Allen, et al.
Clinical and Experimental Pharmacology & Physiology
|
September 1, 1986
Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat
M E Cooper, T J Allen, G Jerums, et al.
The American Journal of Physiology
|
February 12, 1998
Characterization of binding sites for amylin, calcitonin, and CGRP in primate kidney
S Y Chai, G Christopoulos, M E Cooper, et al.
Diabetologia
|
December 29, 1998
Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine
E Roufail, T Soulis, E Boel, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement
|
January 1, 1992
Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors
M E Cooper, J R Rumble, T Gin, et al.
Page
of 25
Search research articles
Search
Showing results (71-80 of 246) with videos related to
Sort By:
Page
of 25
Clinical and Experimental Pharmacology & Physiology
|
March 1, 2008
Angiotensin converting enzyme 2 in the kidney
A Koitka, M E Cooper, M C Thomas, et al.
The Medical Journal of Australia
|
November 10, 2001
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes
G Jerums, M E Cooper, R E Gilbert, et al.
Diabetes
|
April 1, 1993
The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy
R C O'Brien, M E Cooper, G Jerums, et al.
Kidney International
|
August 1, 1996
Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment
T Soulis, M E Cooper, D Vranes, et al.
Diabetologia
|
April 6, 2006
Anaemia in diabetes: Is there a rationale to TREAT?
M C Thomas, M E Cooper, K Rossing, et al.
Clinical and Experimental Pharmacology & Physiology
|
August 1, 1989
Ramipril reduces albuminuria in diabetic rats fed a high protein diet
R C O'Brien, M E Cooper, T J Allen, et al.
Clinical and Experimental Pharmacology & Physiology
|
September 1, 1986
Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat
M E Cooper, T J Allen, G Jerums, et al.
The American Journal of Physiology
|
February 12, 1998
Characterization of binding sites for amylin, calcitonin, and CGRP in primate kidney
S Y Chai, G Christopoulos, M E Cooper, et al.
Diabetologia
|
December 29, 1998
Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine
E Roufail, T Soulis, E Boel, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement
|
January 1, 1992
Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors
M E Cooper, J R Rumble, T Gin, et al.
Page
of 25